Evidence map›Paper›PMID 41706295›Full record

ArticleMolecular diversity2026

A multifunctional 5-fluorouracil prodrug: synthesis, biological evaluation, and antitumor mechanism investigation.

Ran Zhang, Liqing Tang, Jianglong He, Guanyu Jiang, Yingfei Su, Xueping Jiang, Ping Wu, Dongyang Zhang, Sitong Chen, Hao Li and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ran Zhang *School of Biotechnology, Jiangsu University of Science and Technology , Zhenjiang, 212100, Jiangsu , China.
Liqing Tang *School of Biotechnology, Jiangsu University of Science and Technology , Zhenjiang, 212100, Jiangsu , China.
Jianglong HeSchool of Biotechnology, Jiangsu University of Science and Technology , Zhenjiang, 212100, Jiangsu , China.
Guanyu JiangSchool of Biotechnology, Jiangsu University of Science and Technology , Zhenjiang, 212100, Jiangsu , China.
Yingfei SuSchool of Biotechnology, Jiangsu University of Science and Technology , Zhenjiang, 212100, Jiangsu , China.
Xueping JiangSchool of Biotechnology, Jiangsu University of Science and Technology , Zhenjiang, 212100, Jiangsu , China.
Ping WuSchool of Biotechnology, Jiangsu University of Science and Technology , Zhenjiang, 212100, Jiangsu , China.
Dongyang ZhangSchool of Biotechnology, Jiangsu University of Science and Technology , Zhenjiang, 212100, Jiangsu , China.
Sitong ChenSchool of Biotechnology, Jiangsu University of Science and Technology , Zhenjiang, 212100, Jiangsu , China.
Hao LiSchool of Biotechnology, Jiangsu University of Science and Technology , Zhenjiang, 212100, Jiangsu , China.
Zhongzheng GuiSchool of Biotechnology, Jiangsu University of Science and Technology , Zhenjiang, 212100, Jiangsu , China. srizzgui@just.edu.cn.

Funding

National Natural Science Foundation of China 32306387Natural Science Foundation of Jiangsu Province BK20241470
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

5-Fluorouracil prodrugAnti-cancerAntitumor mechanismBiological evaluationPaclitaxel

Identifiers

PMID41706295

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.